MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration

Research output: Contribution to journalArticle

163 Citations (Scopus)

Abstract

MicroRNAs are small RNAs that function as regulators of posttranscriptional gene expression. MicroRNAs are encoded by genes, and processed to form ribonucleoprotein complexes that bind to messenger RNA (mRNA) targets to repress translation or degrade mRNA transcripts. The microRNAs are particularly abundant in the brain where they serve as effectors of neuronal development and maintenance of the neuronal phenotype. They are also expressed in dendrites where they regulate spine structure and function as effectors in synaptic plasticity. MicroRNAs have been evaluated for their roles in brain ischemia, traumatic brain injury, and spinal cord injury, and in functional recovery after ischemia. They also serve as mediators in the brain's response to ischemic preconditioning that leads to endogenous neuroprotection. In addition, microRNAs are implicated in neurodegenerative disorders, including Alzheimer's, Huntington, Parkinson, and Prion disease. The discovery of microRNAs has expanded the potential for human diseases to arise from genetic mutations in microRNA genes or sequences within their target mRNAs. This review discusses microRNA discovery, biogenesis, mechanisms of gene regulation, their expression and function in the brain, and their roles in brain ischemia and injury, neuroprotection, and neurodegeneration.

Original languageEnglish (US)
Pages (from-to)1564-1576
Number of pages13
JournalJournal of Cerebral Blood Flow and Metabolism
Volume30
Issue number9
DOIs
StatePublished - Sep 2010
Externally publishedYes

Fingerprint

MicroRNAs
Ischemia
Wounds and Injuries
Brain
Brain Ischemia
Messenger RNA
Ischemic Preconditioning
Pseudogenes
Prion Diseases
Neuronal Plasticity
Ribonucleoproteins
Neuroprotection
Huntington Disease
Gene Expression Regulation
Regulator Genes
Dendrites
Spinal Cord Injuries
Neurodegenerative Diseases
Brain Injuries
Parkinson Disease

Keywords

  • brain injury
  • microRNA
  • neurodegeneration
  • neuroprotection
  • posttranscriptional gene expression
  • translational repression

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Neurology
  • Medicine(all)

Cite this

@article{bce2d58d41f84dcaa3b774eb5914c67c,
title = "MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration",
abstract = "MicroRNAs are small RNAs that function as regulators of posttranscriptional gene expression. MicroRNAs are encoded by genes, and processed to form ribonucleoprotein complexes that bind to messenger RNA (mRNA) targets to repress translation or degrade mRNA transcripts. The microRNAs are particularly abundant in the brain where they serve as effectors of neuronal development and maintenance of the neuronal phenotype. They are also expressed in dendrites where they regulate spine structure and function as effectors in synaptic plasticity. MicroRNAs have been evaluated for their roles in brain ischemia, traumatic brain injury, and spinal cord injury, and in functional recovery after ischemia. They also serve as mediators in the brain's response to ischemic preconditioning that leads to endogenous neuroprotection. In addition, microRNAs are implicated in neurodegenerative disorders, including Alzheimer's, Huntington, Parkinson, and Prion disease. The discovery of microRNAs has expanded the potential for human diseases to arise from genetic mutations in microRNA genes or sequences within their target mRNAs. This review discusses microRNA discovery, biogenesis, mechanisms of gene regulation, their expression and function in the brain, and their roles in brain ischemia and injury, neuroprotection, and neurodegeneration.",
keywords = "brain injury, microRNA, neurodegeneration, neuroprotection, posttranscriptional gene expression, translational repression",
author = "Julie Saugstad",
year = "2010",
month = "9",
doi = "10.1038/jcbfm.2010.101",
language = "English (US)",
volume = "30",
pages = "1564--1576",
journal = "Journal of Cerebral Blood Flow and Metabolism",
issn = "0271-678X",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - MicroRNAs as effectors of brain function with roles in ischemia and injury, neuroprotection, and neurodegeneration

AU - Saugstad, Julie

PY - 2010/9

Y1 - 2010/9

N2 - MicroRNAs are small RNAs that function as regulators of posttranscriptional gene expression. MicroRNAs are encoded by genes, and processed to form ribonucleoprotein complexes that bind to messenger RNA (mRNA) targets to repress translation or degrade mRNA transcripts. The microRNAs are particularly abundant in the brain where they serve as effectors of neuronal development and maintenance of the neuronal phenotype. They are also expressed in dendrites where they regulate spine structure and function as effectors in synaptic plasticity. MicroRNAs have been evaluated for their roles in brain ischemia, traumatic brain injury, and spinal cord injury, and in functional recovery after ischemia. They also serve as mediators in the brain's response to ischemic preconditioning that leads to endogenous neuroprotection. In addition, microRNAs are implicated in neurodegenerative disorders, including Alzheimer's, Huntington, Parkinson, and Prion disease. The discovery of microRNAs has expanded the potential for human diseases to arise from genetic mutations in microRNA genes or sequences within their target mRNAs. This review discusses microRNA discovery, biogenesis, mechanisms of gene regulation, their expression and function in the brain, and their roles in brain ischemia and injury, neuroprotection, and neurodegeneration.

AB - MicroRNAs are small RNAs that function as regulators of posttranscriptional gene expression. MicroRNAs are encoded by genes, and processed to form ribonucleoprotein complexes that bind to messenger RNA (mRNA) targets to repress translation or degrade mRNA transcripts. The microRNAs are particularly abundant in the brain where they serve as effectors of neuronal development and maintenance of the neuronal phenotype. They are also expressed in dendrites where they regulate spine structure and function as effectors in synaptic plasticity. MicroRNAs have been evaluated for their roles in brain ischemia, traumatic brain injury, and spinal cord injury, and in functional recovery after ischemia. They also serve as mediators in the brain's response to ischemic preconditioning that leads to endogenous neuroprotection. In addition, microRNAs are implicated in neurodegenerative disorders, including Alzheimer's, Huntington, Parkinson, and Prion disease. The discovery of microRNAs has expanded the potential for human diseases to arise from genetic mutations in microRNA genes or sequences within their target mRNAs. This review discusses microRNA discovery, biogenesis, mechanisms of gene regulation, their expression and function in the brain, and their roles in brain ischemia and injury, neuroprotection, and neurodegeneration.

KW - brain injury

KW - microRNA

KW - neurodegeneration

KW - neuroprotection

KW - posttranscriptional gene expression

KW - translational repression

UR - http://www.scopus.com/inward/record.url?scp=77956263239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956263239&partnerID=8YFLogxK

U2 - 10.1038/jcbfm.2010.101

DO - 10.1038/jcbfm.2010.101

M3 - Article

C2 - 20606686

AN - SCOPUS:77956263239

VL - 30

SP - 1564

EP - 1576

JO - Journal of Cerebral Blood Flow and Metabolism

JF - Journal of Cerebral Blood Flow and Metabolism

SN - 0271-678X

IS - 9

ER -